Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ Orbitrap Velos
ORGANISM(S): Mus Musculus (mouse)
TISSUE(S): Primary Cell, Macrophage
DISEASE(S): Colon Cancer
SUBMITTER: Sang-Yeop Lee
LAB HEAD: Chang Hoon Lee
PROVIDER: PXD024512 | Pride | 2022-10-14
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
201123_KRICT_KCH_ADO_1st_01.raw | Raw | |||
201123_KRICT_KCH_ADO_1st_02.raw | Raw | |||
201123_KRICT_KCH_ADO_1st_03.raw | Raw | |||
201123_KRICT_KCH_ADO_1st_04.raw | Raw | |||
201123_KRICT_KCH_ADO_1st_05.raw | Raw |
Items per page: 5 1 - 5 of 48 |
Noh Ji-Yoon JY Lee In Pyo IP Han Na Rae NR Kim Miok M Min Yong Ki YK Lee Sang-Yeop SY Yun Sung Ho SH Kim Seung Il SI Park Tamina T Chung Hyunmin H Park Daeui D Lee Chang Hoon CH
Cellular and molecular gastroenterology and hepatology 20220715 4
<h4>Background & aims</h4>Although cancer immunotherapies are effective for advanced-stage cancers, there are no clinically approved immunotherapies for colon cancers (CRCs). Therefore, there is a high demand for the development of novel therapies. Extracellular adenosine-mediated signaling is considered a promising target for advanced-stage cancers that are nonresponsive to programmed death 1 (PD-1)-/programmed death-ligand 1 (PD-L1)-targeted immunotherapies. In this study, we aimed to elucidat ...[more]